Sumitomo Pharma Co., Ltd.
4506
Xếp hạng trong cổ phiếu
#3218
Sumitomo Pharma Co., Ltd. is a global company involved in the creation,... Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across Japan, North America, China, and other international territories. The company's pharmaceutical offerings address a broad spectrum of medical needs. These include treatments for conditions such as Parkinson's disease, depression, type 2 diabetes, systemic fungal infections, hypertension, pruritus, chronic obstructive pulmonary disease (COPD), angina pectoris, and arrhythmia. Additionally, they manufacture atypical antipsychotics, antiepileptics, carbapenem antibiotics, gastrointestinal products, and specialized medications for Anderson-Fabry disease. Beyond healthcare, Sumitomo Pharma provides food components and enhancement agents like polysaccharides, along with savory flavorings such as soups and bouillons. The company also supplies chemical raw materials, which encompass pharmaceutical excipients, components for personal care products, substances used in coatings and industrial applications, and electronic materials. Moreover, it produces veterinary therapeutic solutions designed for domestic pets, specifically dogs and cats, as well as for various farm animals, including cattle, swine, poultry, horses, and cultivated fish. To drive innovation, Sumitomo Pharma fosters partnerships with several organizations. These collaborators include Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. The company also maintains a joint development agreement with SanBio Company Limited, a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd., and a strategic alliance with Roivant Sciences Ltd. Originally established in 1897, the company, headquartered in Osaka, Japan, was known as Sumitomo Dainippon Pharma Co., Ltd. until it adopted its current name, Sumitomo Pharma Co., Ltd., in April 2022. It functions as a subsidiary of Sumitomo Chemical Company, Limited.
Giá cổ phiếu
$12.27
Vốn hóa thị trường
$5.51B
Thay đổi (1 ngày)
2.20%
Thay đổi (1 năm)
1.68%
Quốc gia
JP
Giao dịch Sumitomo Pharma Co., Ltd. (4506)
Danh mục
Healthcare
Vốn hóa thị trường của Sumitomo Pharma Co., Ltd.(4506)
Vốn hóa thị trường: $5.51B
Tính đến năm October 2026, Sumitomo Pharma Co., Ltd. có vốn hóa thị trường là $5.51B. Theo dữ liệu của chúng tôi, điều này khiến Sumitomo Pharma Co., Ltd. trở thành công ty có giá trị lớn thứ 3218th trên thế giới theo vốn hóa thị trường. Vốn hóa thị trường là tổng giá trị thị trường của tất cả cổ phiếu đang lưu hành của một công ty niêm yết và thường được sử dụng để đo lường giá trị của công ty đó.
Lịch sử vốn hóa thị trường của Sumitomo Pharma Co., Ltd. từ 2009 đến 2026
4506 So với Top 5 phổ biến nhất stocks
